India · Delayed Price · Currency is INR Artemis Medicare Services Statistics
Total Valuation
NSE:ARTEMISMED has a market cap or net worth of INR 47.25 billion. The enterprise value is 49.60 billion.
| Market Cap | 47.25B |
| Enterprise Value | 49.60B |
Important Dates
The next confirmed earnings date is Monday, August 3, 2026.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
NSE:ARTEMISMED has 158.31 million shares outstanding. The number of shares has increased by 1.48% in one year.
| Current Share Class | 158.31M |
| Shares Outstanding | 158.31M |
| Shares Change (YoY) | +1.48% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 3.08% |
| Owned by Institutions (%) | 1.42% |
| Float | 32.29M |
Valuation Ratios
The trailing PE ratio is 45.52 and the forward PE ratio is 35.26. NSE:ARTEMISMED's PEG ratio is 1.24.
| PE Ratio | 45.52 |
| Forward PE | 35.26 |
| PS Ratio | 4.37 |
| PB Ratio | 5.02 |
| P/TBV Ratio | 5.36 |
| P/FCF Ratio | 175.01 |
| P/OCF Ratio | 35.81 |
| PEG Ratio | 1.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.45, with an EV/FCF ratio of 183.68.
| EV / Earnings | 47.86 |
| EV / Sales | 4.59 |
| EV / EBITDA | 26.45 |
| EV / EBIT | 34.90 |
| EV / FCF | 183.68 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.74 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | 9.69 |
| Interest Coverage | 5.81 |
Financial Efficiency
Return on equity (ROE) is 11.63% and return on invested capital (ROIC) is 10.65%.
| Return on Equity (ROE) | 11.63% |
| Return on Assets (ROA) | 6.38% |
| Return on Invested Capital (ROIC) | 10.65% |
| Return on Capital Employed (ROCE) | 11.67% |
| Weighted Average Cost of Capital (WACC) | 6.08% |
| Revenue Per Employee | 5.26M |
| Profits Per Employee | 504,230 |
| Employee Count | 2,055 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 72.11 |
Taxes
In the past 12 months, NSE:ARTEMISMED has paid 354.63 million in taxes.
| Income Tax | 354.63M |
| Effective Tax Rate | 25.48% |
Stock Price Statistics
The stock price has increased by +24.69% in the last 52 weeks. The beta is 0.32, so NSE:ARTEMISMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +24.69% |
| 50-Day Moving Average | 270.81 |
| 200-Day Moving Average | 254.84 |
| Relative Strength Index (RSI) | 67.05 |
| Average Volume (20 Days) | 321,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ARTEMISMED had revenue of INR 10.81 billion and earned 1.04 billion in profits. Earnings per share was 6.56.
| Revenue | 10.81B |
| Gross Profit | 2.38B |
| Operating Income | 1.42B |
| Pretax Income | 1.39B |
| Net Income | 1.04B |
| EBITDA | 1.83B |
| EBIT | 1.42B |
| Earnings Per Share (EPS) | 6.56 |
Balance Sheet
The company has 334.05 million in cash and 2.62 billion in debt, with a net cash position of -2.28 billion or -14.41 per share.
| Cash & Cash Equivalents | 334.05M |
| Total Debt | 2.62B |
| Net Cash | -2.28B |
| Net Cash Per Share | -14.41 |
| Equity (Book Value) | 9.41B |
| Book Value Per Share | 59.04 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was 1.32 billion and capital expenditures -1.05 billion, giving a free cash flow of 270.01 million.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -1.05B |
| Depreciation & Amortization | 405.40M |
| Net Borrowing | -166.08M |
| Free Cash Flow | 270.01M |
| FCF Per Share | 1.71 |
Margins
Gross margin is 21.98%, with operating and profit margins of 13.14% and 9.58%.
| Gross Margin | 21.98% |
| Operating Margin | 13.14% |
| Pretax Margin | 12.87% |
| Profit Margin | 9.58% |
| EBITDA Margin | 16.89% |
| EBIT Margin | 13.14% |
| FCF Margin | 2.50% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.15%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 0.15% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.92% |
| Buyback Yield | -1.48% |
| Shareholder Yield | -1.33% |
| Earnings Yield | 2.19% |
| FCF Yield | 0.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ARTEMISMED is 330.25, which is 10.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 330.25 |
| Price Target Difference | 10.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on September 23, 2021. It was a forward split with a ratio of 10.
| Last Split Date | Sep 23, 2021 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
NSE:ARTEMISMED has an Altman Z-Score of 6.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.08 |
| Piotroski F-Score | 6 |